Distinct Emphysema Subtypes Defined by Quantitative CT Analysis Are Associated with Specific Pulmonary Matrix Metalloproteinases

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2016 Jul 28

PMID 27460105

Citations 23

Authors

Kristoffer Ostridge

Nicholas Williams

Viktoriya Kim

Stephen Harden

Simon Bourne

Ngaire A Coombs

Paul T Elkington

Raul San Jose Estepar

George Washko

Karl J Staples

Tom M A Wilkinson

Affiliations

Soon will be listed here.

Abstract

Background: Emphysema is characterised by distinct pathological sub-types, but little is known about the divergent underlying aetiology. Matrix-metalloproteinases (MMPs) are proteolytic enzymes that can degrade the extracellular matrix and have been identified as potentially important in the development of emphysema. However, the relationship between MMPs and emphysema sub-type is unknown. We investigated the role of MMPs and their inhibitors in the development of emphysema sub-types by quantifying levels and determining relationships with these sub-types in mild-moderate COPD patients and ex/current smokers with preserved lung function.

Methods: Twenty-four mild-moderate COPD and 8 ex/current smokers with preserved lung function underwent high resolution CT and distinct emphysema sub-types were quantified using novel local histogram-based assessment of lung density. We analysed levels of MMPs and tissue inhibitors of MMPs (TIMPs) in bronchoalveolar lavage (BAL) and assessed their relationship with these emphysema sub-types.

Results: The most prevalent emphysema subtypes in COPD subjects were mild and moderate centrilobular (CLE) emphysema, while only small amounts of severe centrilobular emphysema, paraseptal emphysema (PSE) and panlobular emphysema (PLE) were present. MMP-3, and -10 associated with all emphysema sub-types other than mild CLE, while MMP-7 and -8 had associations with moderate and severe CLE and PSE. MMP-9 also had associations with moderate CLE and paraseptal emphysema. Mild CLE occurred in substantial quantities irrespective of whether airflow obstruction was present and did not show any associations with MMPs.

Conclusion: Multiple MMPs are directly associated with emphysema sub-types identified by CT imaging, apart from mild CLE. This suggests that MMPs play a significant role in the tissue destruction seen in the more severe sub-types of emphysema, whereas early emphysematous change may be driven by a different mechanism.

Trial Registration: Trial registration number NCT01701869 .

Citing Articles

Protective Effect of the Total Alkaloid Extract from Bulbus in a Mouse Model of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease.

Wang X, Aga E, Tse W, Tse K, Ye B Int J Chron Obstruct Pulmon Dis. 2024; 19:1273-1289.

PMID: 38881716 PMC: 11178083. DOI: 10.2147/COPD.S459166.

Dietary tannic acid attenuates elastase-induced pulmonary inflammation and emphysema in mice.

Rajasekar N, Gandhi D, Sivanantham A, Ravikumar V, Raj D, Paramasivam S Inflammopharmacology. 2023; 32(1):747-761.

PMID: 37947914 DOI: 10.1007/s10787-023-01381-z.

Spatial Transcriptomics Resolve an Emphysema-Specific Lymphoid Follicle B Cell Signature in Chronic Obstructive Pulmonary Disease.

Rojas-Quintero J, Ochsner S, New F, Divakar P, Xi Yang C, Wu T Am J Respir Crit Care Med. 2023; 209(1):48-58.

PMID: 37934672 PMC: 10870877. DOI: 10.1164/rccm.202303-0507LE.

Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD.

Hristova V, Watson A, Chaerkady R, Glover M, Ackland J, Angerman B ERJ Open Res. 2023; 9(3).

PMID: 37228288 PMC: 10204810. DOI: 10.1183/23120541.00378-2022.

Pulmonary EV miRNA profiles identify disease and distinct inflammatory endotypes in COPD.

Burke H, Cellura D, Freeman A, Hicks A, Ostridge K, Watson A Front Med (Lausanne). 2023; 9:1039702.

PMID: 36590967 PMC: 9797812. DOI: 10.3389/fmed.2022.1039702.

References

Lowrey G, Henderson N, Blakey J, Corne J, Johnson S . MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD. Respir Med. 2008; 102(6):845-51. DOI: 10.1016/j.rmed.2008.01.006. View

Castaldi P, San Jose Estepar R, Mendoza C, Hersh C, Laird N, Crapo J . Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers. Am J Respir Crit Care Med. 2013; 188(9):1083-90. PMC: 3863741. DOI: 10.1164/rccm.201305-0873OC. View

Johannessen A, Skorge T, Bottai M, Grydeland T, Nilsen R, Coxson H . Mortality by level of emphysema and airway wall thickness. Am J Respir Crit Care Med. 2013; 187(6):602-8. DOI: 10.1164/rccm.201209-1722OC. View

Churg A, Wang R, Wang X, Onnervik P, Thim K, Wright J . Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs. Thorax. 2007; 62(8):706-13. PMC: 2117295. DOI: 10.1136/thx.2006.068353. View

Jairam P, van der Graaf Y, Lammers J, Mali W, de Jong P . Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality. Thorax. 2015; 70(8):725-31. DOI: 10.1136/thoraxjnl-2014-206160. View

Haruna A, Muro S, Nakano Y, Ohara T, Hoshino Y, Ogawa E . CT scan findings of emphysema predict mortality in COPD. Chest. 2010; 138(3):635-40. DOI: 10.1378/chest.09-2836. View

Leco K, Waterhouse P, Sanchez O, Gowing K, Poole A, Wakeham A . Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest. 2001; 108(6):817-29. PMC: 200926. DOI: 10.1172/JCI12067. View

DArmiento J, Goldklang M, Hardigan A, Geraghty P, Roth M, Connett J . Increased matrix metalloproteinase (MMPs) levels do not predict disease severity or progression in emphysema. PLoS One. 2013; 8(2):e56352. PMC: 3575373. DOI: 10.1371/journal.pone.0056352. View

Smith B, Austin J, Newell Jr J, DSouza B, Rozenshtein A, Hoffman E . Pulmonary emphysema subtypes on computed tomography: the MESA COPD study. Am J Med. 2014; 127(1):94.e7-23. PMC: 3882898. DOI: 10.1016/j.amjmed.2013.09.020. View

10.

Sverzellati N, Lynch D, Pistolesi M, Kauczor H, Grenier P, Wilson C . PHYSIOLOGIC AND QUANTITATIVE COMPUTED TOMOGRAPHY DIFFERENCES BETWEEN CENTRILOBULAR AND PANLOBULAR EMPHYSEMA IN COPD. Chronic Obstr Pulm Dis. 2015; 1(1):125-132. PMC: 4447143. DOI: 10.15326/jcopdf.1.1.2014.0114. View

11.

Beeh K, Beier J, Kornmann O, Buhl R . Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respir Med. 2003; 97(6):634-9. DOI: 10.1053/rmed.2003.1493. View

12.

Elkington P, Friedland J . Matrix metalloproteinases in destructive pulmonary pathology. Thorax. 2005; 61(3):259-66. PMC: 2080735. DOI: 10.1136/thx.2005.051979. View

13.

Brew K, Nagase H . The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta. 2010; 1803(1):55-71. PMC: 2853873. DOI: 10.1016/j.bbamcr.2010.01.003. View

14.

Chaudhuri R, McSharry C, Spears M, Brady J, Grierson C, Messow C . Sputum matrix metalloproteinase-9 is associated with the degree of emphysema on computed tomography in COPD. Transl Respir Med. 2016; 1(1):11. PMC: 6733425. DOI: 10.1186/2213-0802-1-11. View

15.

Kukkonen M, Tiili E, Vehmas T, Oksa P, Piirila P, Hirvonen A . Association of genes of protease-antiprotease balance pathway to lung function and emphysema subtypes. BMC Pulm Med. 2013; 13:36. PMC: 3680142. DOI: 10.1186/1471-2466-13-36. View

16.

Ostridge K, Wilkinson T . Present and future utility of computed tomography scanning in the assessment and management of COPD. Eur Respir J. 2016; 48(1):216-28. DOI: 10.1183/13993003.00041-2016. View

17.

Culpitt S, Rogers D, Traves S, Barnes P, Donnelly L . Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respir Med. 2005; 99(6):703-10. DOI: 10.1016/j.rmed.2004.10.022. View

18.

Kukkonen M, Tiili E, Hamalainen S, Vehmas T, Oksa P, Piirila P . SERPINE2 haplotype as a risk factor for panlobular type of emphysema. BMC Med Genet. 2011; 12:157. PMC: 3269992. DOI: 10.1186/1471-2350-12-157. View

19.

Hogg J . Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004; 364(9435):709-21. DOI: 10.1016/S0140-6736(04)16900-6. View

20.

Araki T, Nishino M, Zazueta O, Gao W, Dupuis J, Okajima Y . Paraseptal emphysema: Prevalence and distribution on CT and association with interstitial lung abnormalities. Eur J Radiol. 2015; 84(7):1413-8. PMC: 4450117. DOI: 10.1016/j.ejrad.2015.03.010. View